Skip to main content
OpenTrials
Completed

NCT Number: NCT03060668

Optimized Caloric-proteic Nutrition in Critically Ill Patients

In this prospective randomized controlled trial the investigators intend to compare the use of a nutritional therapy based on caloric intake determined by indirect calorimetry and a high protein intake (2.0 to 2.2 g/kg/day) with a nutritional regimen based on 25 Kcal/kg/day and protein intake usually recommended to critically ill patients (1.4 to 1.5 grams/kg/day).

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hospital Sao Domingos

São Luís, Maranhão, 65060-000, Brazil

About this study

OBJECTIVES

To evaluate the effect of nutritional therapy with caloric intake determined by indirect calorimetry and high protein intake (2.0 to 2.2 g/kg/day) compared to nutritional therapy with 25 kcal/kg/day and 1.4 to 1, 5 g/kg/day of protein on short-term outcomes and physical component (PCS) of quality of life after 3 and 6 months of randomization in severe ICU patients.

The primary objective will be the evaluation of the physical component summary (PCS) of SF-36 (Short Form 36), a questionnaire used to evaluate quality of life, validated for the Brazilian population. Patients will be assessed at least 3 and 6 months after randomization.

Secondary objectives: Measurement of handgrip strength measured on the 7th and 14th day of the study and on discharge from the ICU, ICU mortality, hospital mortality, mechanical ventilation time and length of stay in the ICU.

METHODS

The study will include patients over 18 years of age, not pregnant, submitted to mechanical ventilation, whose expectation of stay in the ICU is greater than 3 days.

The sample size was calculated based on the following parameters: patient population under mechanical ventilation, 528, 15% relative risk reduction in the evaluation parameter of the SF-36 tool, Level of significance (α) of 5%, test power of 80%, thus the number of individuals to be sampled will be 294, i.e., two groups of 147 patients. A computer-generated list for randomization and sequentially numbered opaque sealed envelopes is used. The level of significance to reject the null hypothesis will be 5%, that is, a value of p <0.05 will be considered as statistically significant.

Informed consent was obtained from the patient or a next of kin.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Critically ill patients Mechanically ventilated Expected length in the ICU > 3 days

Exclusion criteria

  • Pregnancy Requirement for inspired oxygen (FIO2) > 0.60 High output bronchopleural fistula

Treatment and study plan

Peptamen intense

Other

Study group will receive a nutritional formula containing 1.0 kcal/ml and 93 g/L of protein

Novasource senior

Other

Control group will receive a nutritional formula containing 1.2 kcal/ml and 65 g/L of protein

Primary outcomes

  1. PCS of SF-36

    Time frame: 6 months after randomization

    Physical component summary of Short Form 36

Secondary outcomes

  1. Handgrip strength

    Time frame: 7th, 14th after admission and up to 30 days

    Measured using a calibrated dynamometer

  2. ICU mortality

    Time frame: Up to 30 days

    ICU outcome

  3. Hospital mortality

    Time frame: Up to 6 months

    Hospital outcome

Sponsors and collaborators

Lead sponsor

Hospital Sao Domingos

Other

Registry information

Official study title

Optimized Caloric-proteic Nutrition in Critically Ill Patients: Impact on Short and Long-term Outcomes

Important dates

Study start
2016
Primary completion
2018
Study completion
2018
First posted
Feb 23, 2017
Registry last updated
Mar 16, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.